Skip to main content
Cardiosense Recieves FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure Read the press release

Media Coverage

TMCx has progressed virtually in 2020 including Bootcamp, an intensive diligence and relationship building period designed to initiate…

Keep reading